Characteristics and Outcomes of Patients Ineligible for Transcatheter Mitral Valve Replacement (TMVR): Implications for Future Device Innovation.

CONCLUSIONS: Despite growing experience with TMVR, the subset of MR patients anatomically eligible for TMVR is small and many patients are treated medically. Mortality in these patients remains high, underlining an unmet need for adequate therapeutic alternatives. TMVR devices adapting to broader annular size ranges with smaller ventricular profiles might fill this gap. PMID: 33600355 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33600355?dopt=Abstract

Source: The Journal of Invasive Cardiology - February 21, 2021 Category: Cardiology Tags: J Invasive Cardiol Source Type: research